RT @KDAO2011: Sustained benefits #voclosporin in #LupusNephritis AURORA2 - 2 year study POS0186: ðno unexpected AEs;
Tweet Content
Sustained benefits #voclosporin in #LupusNephritis AURORA2 - 2 year study POS0186:
👉no unexpected AEs; rate of AEs⬇️over time
👉COVID19 seen in 12 controls, 7 VCS
👉4 deaths w/control arm vs 0 deaths w/ VCS
👉GFR & sCr & reduction in UPCR remained stable #EULAR2022 @rheumnow
Show on Archive Page
On
Display in Search Results
On
PDQ
Off